These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
73 related items for PubMed ID: 3037082
1. Human antibodies to ovarian cancer antigens secreted by lymphoblastoid cell lines. Al-Azzawi F, Stimson WH, Govan AD. J Clin Lab Immunol; 1987 Feb; 22(2):71-5. PubMed ID: 3037082 [Abstract] [Full Text] [Related]
4. Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer. Cote RJ, Morrissey DM, Oettgen HF, Old LJ. Fed Proc; 1984 Jun; 43(9):2465-9. PubMed ID: 6327400 [Abstract] [Full Text] [Related]
5. In vitro growth of B lymphocytes infiltrating human melanoma tissue by transformation with EBV: evidence for secretion of anti-melanoma antibodies by some transformed cells. Watson DB, Burns GF, Mackay IR. J Immunol; 1983 May; 130(5):2442-7. PubMed ID: 6300247 [Abstract] [Full Text] [Related]
6. Specificity and isotype of Rh specific antibodies produced by human B-cell lines established from alloimmunized Rh negative women. Pasha RP, Bahrami ZS, Niroomanesh S, Ramzi F, Razavi AR, Shokri F. Transfus Apher Sci; 2005 Oct; 33(2):119-27. PubMed ID: 16103012 [Abstract] [Full Text] [Related]
7. Epstein-Barr virus-induced lymphoblastoid cell lines from seropositive adult donors and their HLA-antigens. Akiyama N, Ohsawa N, Kusaba R, Inou T, Takada M. Jpn J Exp Med; 1981 Feb; 51(1):1-7. PubMed ID: 6273617 [Abstract] [Full Text] [Related]
8. Specificity of monoclonal antibodies to an EBV transformed B-cell line. Schröder J, Suomalainen HA, Parkkinen E, Lundqvist C, Wada G, Koskimies S. Med Biol; 1982 Oct; 60(5):255-9. PubMed ID: 6296556 [Abstract] [Full Text] [Related]
9. Human anti-pneumococci antibody produced by an Epstein Barr virus (EBV)-immortalized cell line. Steinitz M, Tamir S, Goldfarb A. J Immunol; 1984 Feb; 132(2):877-82. PubMed ID: 6317751 [Abstract] [Full Text] [Related]
10. Monoclonal antibody against human ovarian tumor-associated antigens. Poels LG, Peters D, van Megen Y, Vooijs GP, Verheyen RN, Willemen A, van Niekerk CC, Jap PH, Mungyer G, Kenemans P. J Natl Cancer Inst; 1986 May; 76(5):781-91. PubMed ID: 3517452 [Abstract] [Full Text] [Related]
15. The Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines (LCL) as stimulating cells in mixed lymphocyte culture (MLC). Wasik M, Matej H, Duś D, Myc A. Arch Immunol Ther Exp (Warsz); 1983 Apr; 31(6):879-85. PubMed ID: 6331341 [Abstract] [Full Text] [Related]
16. Transformation of human colostrum lymphocytes with Epstein-Barr virus. Shinmoto H, Dosako S, Tanaka S. Tokai J Exp Clin Med; 1992 Oct; 17(3-4):129-32. PubMed ID: 1338659 [Abstract] [Full Text] [Related]
17. Inhibition of human lymphoblastoid cell line proliferation by ascites fluids from ovarian cancer patients. Hess AD, Gall SA, Dawson JR. Cancer Res; 1980 Dec; 40(12):4495-500. PubMed ID: 7438082 [Abstract] [Full Text] [Related]
18. Human lymphoblast cell lines: antibody-dependent cytotoxicity. Lefebre JC, Petitprez A, Juy D, Bona C. Eur J Immunol; 1975 Apr; 5(4):266-70. PubMed ID: 1234057 [Abstract] [Full Text] [Related]
19. Immunoglobulin expression by human B lymphocytes clonally transformed by Epstein Barr virus. Brown NA, Miller G. J Immunol; 1982 Jan; 128(1):24-9. PubMed ID: 6274955 [Abstract] [Full Text] [Related]
20. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells. Wasik M, Myc A, Matej H, Rudzka L. Arch Immunol Ther Exp (Warsz); 1983 Jan; 31(6):871-8. PubMed ID: 6331340 [Abstract] [Full Text] [Related] Page: [Next] [New Search]